Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection
Anpac Bio, USAFebruary 1, 2021 GMT
SAN JOSE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that a new U.S. patent titled “Apparatus for Detecting Tumor Cells” (patent number 10,895,573) was granted to the Company by the United States Patent and Trademark Office on January 19, 2021, AnPac Bio’s 20th patent granted in the U.S. The patent contains 38 claims and covers a range of novel features for multi-cancer detection, which has become increasingly important, and covers the cancer detection apparatus, components of the apparatus, reagents, detection mechanisms, and a wide